Cargando…
Safety of intranasal corticosteroids in acute rhinosinusitis
Treatment guidelines for acute rhinosinusitis (RS) recommend the use of intranasal corticosteroids (INSs) as monotherapy or adjunctive therapy. However, the adverse event (AE) profiles of oral glucocorticoids, which result largely from the systemic absorption of those agents, have engendered concern...
Autor principal: | Demoly, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115254/ https://www.ncbi.nlm.nih.gov/pubmed/19144302 http://dx.doi.org/10.1016/j.amjoto.2007.11.004 |
Ejemplares similares
-
Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11
por: Tanno, Luciana Kase, et al.
Publicado: (2015) -
Association of Intranasal and Neurogenic Dural Inflammation in Experimental Acute Rhinosinusitis
por: Lovrenčić, Luka, et al.
Publicado: (2020) -
Using intranasal corticosteroids
por: Fowler, James, et al.
Publicado: (2021) -
Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B
por: Kern, Eugene B, et al.
Publicado: (2007) -
The subtle nuances of intranasal corticosteroids
por: Fowler, James, et al.
Publicado: (2021)